Complement activation and expression of membrane regulators in the middle ear mucosa in otitis media with effusion
Authors:
- 1 June 1999
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 116 (3) , 401-409
Abstract
The aetiopathogenesis of chronic otitis media with effusion (OME) in children is not yet fully understood. OME is characterized by metaplasia of the epithelium and accumulation of sticky, glue-like effusion in the middle ear containing different mediators of inflammation, including activation fragments of the complement system. Here we examined whether the fluid phase complement activation is reflected in the middle ear mucosa and how the mucosa is protected against the cytolytic activity of complement. Mucosal biopsies from 18 middle ears of children with a history of chronic OME were taken. The biopsies were analysed by immunofluorescence microscopy after staining for complement fragments iC3b/C3c, C3d and C9, and regulators membrane cofactor protein (MCP; CD46), decay-accelerating factor (DAF; CD55) and protectin (CD59). There was a strong staining for iC3b/C3c, and a weaker one for C3d and C9 on the surface of the middle ear epithelial cells of OME patients but not in controls without OME. MCP was expressed on the hyperplastic three to four outer cell layers of the epithelium, while CD59 was expressed throughout the middle ear mucosa. The results suggest a strong ongoing complement activation and consequent inflammation in the middle ear cavity. Unrestricted complement damage of the epithelial lining is prevented by the strong expression of MCP and CD59.Keywords
This publication has 24 references indexed in Scilit:
- PCR-based detection of bacterial DNA after antimicrobial treatment is indicative of persistent, viable bacteria in the chinchilla model of otitis mediaAmerican Journal of Otolaryngology, 1996
- Cytokines, Immunoglobulins, and Bacterial Pathogens in Middle Ear EffusionsJAMA Otolaryngology–Head & Neck Surgery, 1995
- Chronic Otitis Media With Effusion in Infancy: How Frequent Is It? How Does It Develop?JAMA Otolaryngology–Head & Neck Surgery, 1995
- Phospholipid-anchored and transmembrane versions of either decay-accelerating factor or membrane cofactor protein show equal efficiency in protection from complement-mediated cell damage.Journal of Experimental Medicine, 1991
- Soluble Human Complement Receptor Type 1: In Vivo Inhibitor of Complement Suppressing Post-Ischemic Myocardial Inflammation and NecrosisScience, 1990
- Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids.Journal of Experimental Medicine, 1987
- Aneurysm of the Extracranial Carotid ArteryJAMA Otolaryngology–Head & Neck Surgery, 1986
- Complement in Chronic Secretory Otitis Media: C3 Breakdown and C3 Splitting ActivityJAMA Otolaryngology–Head & Neck Surgery, 1984
- BACTERIA ASSOCIATED WITH ACUTE OTITIS MEDIA HAVE HIGH Clq BINDING CAPACITYActa Pathologica Microbiologica Scandinavica Section C Immunology, 1980
- Improved mountant for immunofluorescence preparations.Journal of Clinical Pathology, 1974